Global Oocyte Cryopreservation Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028

Global Oocyte Cryopreservation Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028

Report Code: KNJ1117272 | No. of Pages: 106 | Category: Services
Publisher: GRD Survey | Date of Publish: Jan-2022
Executive Summary

According to GRD Survey data, the global Oocyte Cryopreservation market is estimated at  million US$ in 2021 and is expected to  million US$ by the end of 2028, growing at a CAGR of % in the forecast period from 2022 to 2028.

This report studies the Oocyte Cryopreservation market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Oocyte Cryopreservation in these regions, from 2016 to 2027, covering
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
    Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
    South America (Brazil, Argentina, Colombia, etc.)
    Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
    Slow-cooling Method

    Flash-freezing Process (Vitrification)

Market Snapshot, By Application
    25-30 Year Old Female

    30-35 Year Old Female

    35-40 Year Old Female

    Others

Main Market Players Analyzed in this report, including:
    West Coast Fertility Centers

    Shady Grove Fertility

    San Diego Fertility Center (SDFC)

    Reproductive Biology Associates

    Prelude Fertility

    Mayo Clinic

    Kindbody

    HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)

    Extend Fertility

    CReATe Fertility Center

    CCRM IVF

    Anova Fertility


The study objectives of this report are:
    To study and analyze the global Oocyte Cryopreservation market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
    To understand industry structure of Oocyte Cryopreservation market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To identify the key global Oocyte Cryopreservation manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Oocyte Cryopreservation market with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Oocyte Cryopreservation submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Oocyte Cryopreservation are as follows:
    History Year: 2016-2020
    Base Year: 2020
    Estimated Year: 2021
    Forecast Year 2021 to 2027

This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1  Market Definition & Scope
    1.1  Definition & Scope
    1.2 Oocyte Cryopreservation Product Specifications
    1.3  Main Events (Entry, M&A, Exit, Technology and Capital Activity)
    1.4 Global Oocyte Cryopreservation Market Performance and Outlook

2 Market Development Performance under COVID-19
    2.1 Influencing Factors of Industry Development in the Next Five Years
        2.1.1 Drivers
        2.1.2 Restraints
        2.1.3 Opportunities
    2.2 Porter’s Five Forces Analysis
    2.3 Comparison of Alternatives and Oocyte Cryopreservation

3 3 Industrial Lift Cycle and Main Buyers Analysis
    3.1 Industry Life Cycle Analysis
    3.2 Key Buying Industries/Consumers
        3.2.1 Major Buyers in 25-30 Year Old Female

        3.2.2 Major Buyers in 30-35 Year Old Female


4 Market Segment: by Type
    4.1 Oocyte Cryopreservation Type Introduction
        4.1.1 Slow-cooling Method

        4.1.2 Flash-freezing Process (Vitrification)
    4.2 Global Oocyte Cryopreservation Revenue by Type 2016-2021

5 Market Segment: by Application
    5.1 Oocyte Cryopreservation Type Introduction
        5.1.1 25-30 Year Old Female

        5.1.2 30-35 Year Old Female

        5.1.3 35-40 Year Old Female

        5.1.3 Others
    5.2 Global Oocyte Cryopreservation Revenue by Application 2016-2021

6 Marke Segment: by Region
    6.1 Global Oocyte Cryopreservation Market by Region
    6.2 North America Oocyte Cryopreservation Market 2016-2021
    6.3 Europe Oocyte Cryopreservation Market 2016-2021
    6.4 Asia Pacific Oocyte Cryopreservation Market 2016-2021
    6.5 South America Oocyte Cryopreservation Market 2016-2021
    6.6 Middle East and Africa Oocyte Cryopreservation Market 2016-2021

7 North America
    7.1 North America Oocyte Cryopreservation Market by Country 2016-2021
    7.2 United States
    7.3 Canada
    7.4 Mexico

8 Europe
    8.1 Europe Oocyte Cryopreservation Market by Country 2016-2021
    8.2 Germany
    8.3 France
    8.4 UK
    8.5 Italy
    8.6 Russia
    8.7 Spain

9 Asia Pacific
    9.1 Asia Pacific Oocyte Cryopreservation Market by Country 2016-2021
    9.2 China
    9.3 Japan
    9.4 Korea
    9.5 Southeast Asia
    9.6 India
    9.7 Australia

10 South America
    10.1 South America Oocyte Cryopreservation Market by Country 2016-2021
    10.2 Brazil
    10.3 Argentina
    10.4 Colombia

11 Middle East and Africa
    11.1 Middle East and Africa Oocyte Cryopreservation Market by Country 2016-2021
    11.2 Turkey
    11.3 Saudi Arabia
    11.4 South Africa

12 Key Participants Company Information
    12.1 West Coast Fertility Centers

        12.1.1 West Coast Fertility Centers
 Company Information
        12.1.2 West Coast Fertility Centers
 Oocyte Cryopreservation Product Portfolio, Specification and Application
        12.1.3 West Coast Fertility Centers
 Oocyte Cryopreservation Revenue and Gross Margin (2019-2021)
        12.1.4 West Coast Fertility Centers
 Key Development
    12.2 Shady Grove Fertility

        12.2.1 Shady Grove Fertility
 Company Information
        12.2.2 Shady Grove Fertility
 Oocyte Cryopreservation Product Portfolio, Specification and Application
        12.2.3 Shady Grove Fertility
 Oocyte Cryopreservation Revenue and Gross Margin (2019-2021)
        12.2.4 Shady Grove Fertility
 Key Development
    12.3 San Diego Fertility Center (SDFC)

        12.3.1 San Diego Fertility Center (SDFC)
 Company Information
        12.3.2 San Diego Fertility Center (SDFC)
 Oocyte Cryopreservation Product Portfolio, Specification and Application
        12.3.3 San Diego Fertility Center (SDFC)
 Oocyte Cryopreservation Revenue and Gross Margin (2019-2021)
        12.3.4 San Diego Fertility Center (SDFC)
 Key Development
    12.4 Reproductive Biology Associates

        12.4.1 Reproductive Biology Associates
 Company Information
        12.4.2 Reproductive Biology Associates
 Oocyte Cryopreservation Product Portfolio, Specification and Application
        12.4.3 Reproductive Biology Associates
 Oocyte Cryopreservation Revenue and Gross Margin (2019-2021)
        12.4.4 Reproductive Biology Associates
 Key Development
    12.5 Prelude Fertility

        12.5.1 Prelude Fertility
 Company Information
        12.5.2 Prelude Fertility
 Oocyte Cryopreservation Product Portfolio, Specification and Application
        12.5.3 Prelude Fertility
 Oocyte Cryopreservation Revenue and Gross Margin (2019-2021)
        12.5.4 Prelude Fertility
 Key Development
    12.6 Mayo Clinic

        12.6.1 Mayo Clinic
 Company Information
        12.6.2 Mayo Clinic
 Oocyte Cryopreservation Product Portfolio, Specification and Application
        12.6.3 Mayo Clinic
 Oocyte Cryopreservation Revenue and Gross Margin (2019-2021)
        12.6.4 Mayo Clinic
 Key Development
    12.7 Kindbody

        12.7.1 Kindbody
 Company Information
        12.7.2 Kindbody
 Oocyte Cryopreservation Product Portfolio, Specification and Application
        12.7.3 Kindbody
 Oocyte Cryopreservation Revenue and Gross Margin (2019-2021)
        12.7.4 Mayo Clinic
 Key Development
    12.9 Extend Fertility

        12.9.1 Extend Fertility
 Company Information
        12.9.2 Extend Fertility
 Oocyte Cryopreservation Product Portfolio, Specification and Application
        12.9.3 Extend Fertility
 Oocyte Cryopreservation Revenue and Gross Margin (2019-2021)
        12.9.4 Extend Fertility
 Key Development
    12.8 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)

        12.8.1 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
 Company Information
        12.8.2 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
 Oocyte Cryopreservation Product Portfolio, Specification and Application
        12.8.3 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
 Oocyte Cryopreservation Revenue and Gross Margin (2019-2021)
        12.8.4 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
 Key Development
    12.11 CCRM IVF

        12.11.1 CCRM IVF
 Company Information
        12.11.2 CCRM IVF
 Oocyte Cryopreservation Product Portfolio, Specification and Application
        12.11.3 CCRM IVF
 Oocyte Cryopreservation Revenue and Gross Margin (2019-2021)
        12.11.4 CCRM IVF
 Key Development
    12.12 Anova Fertility

        12.12.1 Anova Fertility
 Company Information
        12.12.2 Anova Fertility
 Oocyte Cryopreservation Product Portfolio, Specification and Application
        12.12.3 Anova Fertility
 Oocyte Cryopreservation Revenue and Gross Margin (2019-2021)
        12.12.4 Anova Fertility
 Key Development

13 Global Oocyte Cryopreservation Market Forecast by Region by Type and by Application
    13.1 Global Oocyte Cryopreservation Revenue Forecast 2022-2027
    13.2 Global Oocyte Cryopreservation Forecast by Regions
    13.3 Global Oocyte Cryopreservation Forecast by Type
    13.4 Global Oocyte Cryopreservation Forecast by Application

14 Analyst Views and Conclusions

15 Methodology and Data Source
    15.1 Methodology
    15.2 Research Data Source
        15.2.1 Secondary Data
        15.2.2 Primary Data
        15.2.3 Market Size Estimation
    15.3 Legal Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com